Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Employers should keep in mind that indication-based coverage decisions (such as covering GLP-1 drugs for diabetes treatment but not for treatment of obesity or other conditions, such as addiction) can potentially raise concerns under the Americans with Disabilities Act (ADA), the ACA, HIPAAs nondiscrimination requirements, or the Mental Health Parity and Addiction Equity Act, among other laws
Prior pancreatitis, gallbladder disease, kidney problems, diabetic retinopathy, significant gastrointestinal symptoms, and use of insulin or sulfonylureas may require closer risk assessment rather than automatic exclusion
6 Given the reduced appetite and potential for muscle loss, protein needs are generally higher for individuals on GLP-1 therapy compared to standard recommendations
This product is not intended to diagnose, treat, cure, or prevent any disease
A personalized evaluation can help determine which option aligns best with your needs, ensuring both safety and effectiveness in your weight management journey
US$ 22.87
US$ 29.88
US$ 26.21
US$ 27.15
US$ 29.86
US$ 29.67
US$ 27.99
US$ 21.88
US$ 29.62
US$ 25.92
US$ 22.81
